© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 7, 626-628,
April 7, 1999
© 1999 Oxford University Press
REPORTS |
Comparison of Prophylactic Oophorectomy Specimens From Carriers and Noncarriers of a BRCA1 or BRCA2 Gene Mutation
Affiliations of authors: J. F. Stratton, Department of Obstetrics and Gynaecology, Rosie Maternity Hospital, Cambridge, U.K.; C. H. Buckley, Department of Reproductive Pathology, St. Mary's Hospital for Women and Children, Manchester, U.K.; D. Lowe, St. Bartholomew's Hospital, London, U.K.; B. A. J. Ponder, Department of Oncology, Addenbrooke's Hospital, Cambridge.
Correspondence to: Bruce A. J. Ponder, Ph.D., F.R.C.P., Cancer Research Campaign Department of Oncology, University of Cambridge, Cambridge Institute of Medical Research, Addenbrooke's Hospital, Hills Rd., Cambridge CB2 2XY, U.K.
BACKGROUND: The natural history of ovarian cancer is not well understood and, to date, there is conflicting evidence as to whether or not there is a demonstrable precursor lesion. Some women at high risk of developing ovarian cancer because of their family history elect to have a prophylactic oophorectomy. To determine whether or not a recognizable premalignant lesion could be defined in familial ovarian carcinogenesis, we reviewed ovarian tissue specimens from women whose ovaries were removed prophylactically before gene testing became available and who were tested subsequently for BRCA1 or BRCA2 gene mutations. METHODS: We analyzed ovarian tissue specimens from 37 women. The specimens were examined for the presence of the following four features: inclusion cysts, clefts and fissures, ovarian epithelial metaplasia, and the presence of papillae on the ovarian surface epithelium. The specimens were also examined closely for the presence of dysplasia and occult neoplasia. Furthermore, the occurrence of endometriosis and benign ovarian tumors was documented in these women. The protein truncation test, nonradioactive single-stranded conformation polymorphism analysis, and heteroduplex analysis, followed by DNA sequencing, were used to identify BRCA1 or BRCA2 mutations in either blood samples or ovarian tissue specimens. RESULTS: Eleven women had inherited a mutated BRCA1 or BRCA2 gene; 26 women had not. There was no difference between these groups for any of the features studied. CONCLUSIONS: Our data suggest that many of the histologic "abnormalities" described in "normal" ovaries are, in fact, variations of the normal and are not associated with the development of cancer.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Chene, F. Penault-Llorca, G. Le Bouedec, F. Mishellany, M.M. Dauplat, P. Jaffeux, B. Aublet-Cuvelier, J.L. Pouly, P. Dechelotte, and J. Dauplat Ovarian epithelial dysplasia after ovulation induction: time and dose effects Hum. Reprod., January 1, 2009; 24(1): 132 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Levanon, C. Crum, and R. Drapkin New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact J. Clin. Oncol., November 10, 2008; 26(32): 5284 - 5293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Guillem, W. C. Wood, J. F. Moley, A. Berchuck, B. Y. Karlan, D. G. Mutch, R. F. Gagel, J. Weitzel, M. Morrow, B. L. Weber, et al. ASCO/SSO Review of Current Role of Risk-Reducing Surgery in Common Hereditary Cancer Syndromes J. Clin. Oncol., October 1, 2006; 24(28): 4642 - 4660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Parthasarathy Architectures of Genetic Medicine: Comparing Genetic Testing for Breast Cancer in the USA and the UK Social Studies of Science, February 1, 2005; 35(1): 5 - 40. [Abstract] [PDF]
|
|
|
|
 |
|
 M. A. Brewer, J. Ranger-Moore, A. Baruche, D. S. Alberts, M. Greene, D. Thompson, Y. Liu, J. Davis, and P. H. Bartels Exploratory Study of Ovarian Intraepithelial Neoplasia Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 299 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Stewart, T. D. Querec, A. R. Ochman, B. N. Gruver, R. Bao, J. S. Babb, T. S. Wong, T. Koutroukides, A. D. Pinnola, A. Klein-Szanto, et al. Characterization of a Carcinogenesis Rat Model of Ovarian Preneoplasia and Neoplasia Cancer Res., November 15, 2004; 64(22): 8177 - 8183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Hogg and M. Friedlander Biology of Epithelial Ovarian Cancer: Implications for Screening Women at High Genetic Risk J. Clin. Oncol., April 1, 2004; 22(7): 1315 - 1327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Brewer, K. Johnson, M. Follen, D. Gershenson, and R. Bast Jr. Prevention of Ovarian Cancer: Intraepithelial Neoplasia Clin. Cancer Res., January 1, 2003; 9(1): 20 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gregoire, R. Rabah, E.-M. Schmelz, A. Munkarah, P. C. Roberts, and W. D. Lancaster Spontaneous Malignant Transformation of Human Ovarian Surface Epithelial Cells in Vitro Clin. Cancer Res., December 1, 2001; 7(12): 4280 - 4287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Auersperg, A. S. T. Wong, K.-C. Choi, S. K. Kang, and P. C. K. Leung Ovarian Surface Epithelium: Biology, Endocrinology, and Pathology Endocr. Rev., April 1, 2001; 22(2): 255 - 288. [Abstract] [Full Text]
|
|
|
|
|
|
A. Eisen, T. R. Rebbeck, W. C. Wood, and B. L. Weber Prophylactic Surgery in Women With a Hereditary Predisposition to Breast and Ovarian Cancer J. Clin. Oncol., May 9, 2000; 18(9): 1980 - 1995. [Abstract] [Full Text] [PDF]
|
|